Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Animal modeling an oligodendrogliopathy - multiple system atrophy.
Estimating a Preference-Based Index for an Eight-Dimensional Health State Classification System for Multiple Sclerosis.
Causes, consequences, and cures for neuroinflammation mediated via the locus coeruleus: noradrenergic signaling system.
Demyelinating disease and psoriasis: Interferon versus dimethyl fumarate.
Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity nervous pathways.
Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis.
Neuromyelitis optica: Contribution of therapeutic responses markers monitoring in patients given rituximab.
The putative acceleration of optic neuritis when combined with chronic hepatitis B.
Diagnostic value of visual evoked potentials for clinical diagnosis of multiple sclerosis.
Fibrillary glomerulonephritis combined with chronic inflammatory demyelinating polyneuropathy.
Evaluator-blinded trial evaluating nurse-led immunotherapy DEcision Coaching In persons with relapsing-remitting Multiple Sclerosis (DECIMS) and accompanying process evaluation: study protocol for a cluster randomised controlled trial.
Ultrasound of inherited vs. acquired demyelinating polyneuropathies.
Resolution of Acute Disseminated Encephalomyelitis Following Termination of Pregnancy.
Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity.
Reliability and Repeatability of the Hoffmann Sign.
Gait characteristics of multiple sclerosis patients in the absence of clinical disability.
Natalizumab treatment in multiple sclerosis: the experience from two Brazilian MS centers.
Differential expression of glucose-metabolizing enzymes in multiple sclerosis lesions.
Application of metabolomics in autoimmune diseases: Insight into biomarkers and pathology.
Measurement and maintenance of reserve in multiple sclerosis.
A Long Term Analysis of The Clinical And Cost Effectiveness of Glatiramer Acetate From The Uk Multiple Sclerosis Risk Sharing Scheme.
Disease-modifying treatments for multiple sclerosis - a review of approved medications.
Protective effect of naringin on 3-nitropropionic acid-induced neurodegeneration through the modulation of matrix metalloproteinases and glial fibrillary acidic protein.
Steroids for chronic inflammatory demyelinating polyradiculoneuropathy: evidence base and clinical practice.
NFATc1 deficiency in T cells protects mice from experimental autoimmune encephalomyelitis.

Pages